Type 2 Diabetes: Prevalence, Insulin Resistance, and Contrast with Type 1
Type 2 diabetes (T2D) accounts for 90–95% of all diabetes cases globally. It is a metabolic disorder of insulin resistance and relative insulin deficiency.
Pathophysiology
- Insulin resistance in muscle, liver, adipose → ↓ glucose uptake, ↑ hepatic gluconeogenesis.
- β-cell compensation fails over time → relative insulin deficiency.
- Glucagon dysregulation (α-cell resistance to insulin) → ↑ hepatic glucose output.
- Incretin defect (↓ GLP-1, GIP effect).
Risk Factors
- Obesity (central), sedentary lifestyle, aging, family history, race/ethnicity (high-risk: Black, Hispanic, Native American, Asian), GDM history, PCOS, metabolic syndrome.
Contrast with Type 1 (T1D)
| Feature | T1D | T2D |
|---|---|---|
| Onset | Childhood/young adult (any age) | Adult (increasing in youth) |
| Pathology | Autoimmune β-cell destruction | Insulin resistance + β-cell failure |
| Insulin | Absolute deficiency | Relative deficiency |
| Ketoacidosis | Common at onset | Rare (HHS more typical) |
| Treatment | Insulin mandatory | Lifestyle → metformin → add-ons → insulin |
